OYEN, Willem Jozef Gerard
 Distribuzione geografica
Continente #
NA - Nord America 33.457
EU - Europa 4.431
AF - Africa 916
AS - Asia 606
OC - Oceania 45
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 14
Totale 39.497
Nazione #
US - Stati Uniti d'America 33.233
FI - Finlandia 1.358
IE - Irlanda 1.053
NG - Nigeria 912
FR - Francia 561
DE - Germania 416
NL - Olanda 380
CN - Cina 277
GB - Regno Unito 237
CA - Canada 219
IT - Italia 197
TR - Turchia 110
IL - Israele 91
SE - Svezia 73
IN - India 48
RU - Federazione Russa 48
AU - Australia 33
IR - Iran 26
CL - Cile 19
SG - Singapore 15
UA - Ucraina 14
A2 - ???statistics.table.value.countryCode.A2??? 13
ES - Italia 13
NZ - Nuova Zelanda 12
RO - Romania 11
HK - Hong Kong 10
JP - Giappone 10
PL - Polonia 10
GR - Grecia 8
AT - Austria 7
BE - Belgio 7
CH - Svizzera 6
DK - Danimarca 6
MD - Moldavia 6
NO - Norvegia 5
CO - Colombia 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
BR - Brasile 3
MY - Malesia 3
BD - Bangladesh 2
BG - Bulgaria 2
EG - Egitto 2
LI - Liechtenstein 2
LK - Sri Lanka 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
KR - Corea 1
LU - Lussemburgo 1
MA - Marocco 1
MN - Mongolia 1
MT - Malta 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 39.497
Città #
Chandler 7.384
Wilmington 6.844
San Mateo 2.585
Ann Arbor 1.399
Helsinki 1.358
Leawood 1.221
Lawrence 1.117
Princeton 1.117
Dublin 1.048
Boardman 1.005
Benin City 911
Fairfield 682
Woodbridge 641
New York 562
Paris 553
Ashburn 379
Amsterdam 370
Seattle 340
San Diego 312
Shanghai 262
London 212
Toronto 196
Norwalk 128
Kocaeli 103
Milan 98
Falkenstein 53
Los Angeles 53
Phoenix 36
Pune 35
Houston 31
Monmouth Junction 30
Moscow 29
Redmond 28
Des Moines 26
Clearwater 14
Hanover 13
Andover 12
Cambridge 12
Redwood City 12
Abbiategrasso 11
Barletta 7
Frankfurt am Main 7
Las Vegas 7
Auckland 6
Brussels 6
Chisinau 6
Istanbul 6
Kemerovo 6
Sydney 6
Saint Paul 5
Santa Clara 5
Singapore 5
Athens 4
Augusta 4
Berlin 4
Chicago 4
Hangzhou 4
Jacksonville 4
Laval 4
Melbourne 4
Nanjing 4
Sacramento 4
Saint Louis 4
Trapani 4
Winnipeg 4
Birmingham 3
Central 3
Collegeville 3
Columbus 3
Cupertino 3
Eden Prairie 3
Hamilton 3
Houilles 3
Newark 3
Perth 3
Staten Island 3
Stockholm 3
São Luís 3
Tappahannock 3
Tokyo 3
Tortona 3
Vancouver 3
Adelaide 2
Apo 2
Beaverton 2
Belfast 2
Belgrade 2
Bintulu 2
Blythewood 2
Bogotá 2
Camponaraya 2
Christchurch 2
Cinisello Balsamo 2
Copenhagen 2
Dambulla 2
Doylestown 2
Fisciano 2
Florence 2
Garza García 2
Giza 2
Totale 31.433
Nome #
18-F fluorodeoxygenase (FDG) positron emission tomography (PET) scanning prior to radical lung radiotherapy. A retrospective audit of practice 73
(18)FDG-PET for staging (non)seminomatous germ cell tumours [(N)SGCT] and for evaluation of postchemotherapy residual masses. 71
Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients 66
PET-CT for response assessment and treatment adaptation in head and neck cancer 63
New targeted probes for radioimaging of angiogenesis 62
The Role of FDG-PET in the Assessment of Thyroid Nodules with an Indeterminant or Suspicious Cytologic Diagnosis 62
2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study 61
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 60
F-18-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation 59
F-18-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis 59
Abscopal effect of radiotherapy in a patient with metastatic diffuse-type giant cell tumor 58
Effect of the positron range on the spatial resolution of a new generation pre-clinical PET using fluorine-18, gallium-68, zirconium-89 and iodine-124 58
18F-FLT-PET for the evaluation of MEK inhibitor AZD6244 57
Kidney protection during peptide receptor radionuclide therapy (PRRT) 57
F-18-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients 57
[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer 57
F-18-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis 56
Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer 56
Albumin derived peptides efficiently reduce renal uptake of radiolabeled peptides 56
A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis 56
F-18-FDG PET of thyroid nodules with inconclusive cytologic results - Reply 55
Radioimmunotherapy with I-131-cG250 monoclonal antibody in patients with metastasized RCC, a phase I/II study. 55
[F-18]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma 55
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer 54
Background-subtracted optimal threshold segmentation algorithm for FDG-PET based GTV delineation: Theory and experimental validation 54
F-18-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis 54
F-18-FDG PET AS A PREDICTOR OF PULMONARY FUNCTION IN SARCOIDOSIS 54
Improved selection of patients for hepatic surgery of colorectal liver metastases with FDG-PET: A randomized study 53
Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: Report of a case 53
F-18-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality 53
The role of megalin in the renal uptake of radiolabeled peptides 52
Reducing renal uptake of radiolabeled peptides using albumin fragments 52
SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA 52
Progress in nuclear medicine procedures in head and neck oncology 52
CAN FOG-PET PREDICT RADIATION TREATMENT OUTCOME IN HEAD AND NECK CANCER? 52
Clinical application of FDG-PET/CT in metastatic infections 52
A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER 52
PET and SPECT Imaging of a Radio labeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with Cu-64, Ga-68, and In-111 52
EANM Focus 1: one small step for two men, one giant leap for a specialty 51
Comparison of liver SUV using unenhanced CT versus contrast- enhanced CT for attenuation correction in 18 F-FDGPET/CT 51
LOCALIZATION OF INFECTION IN HIV ANTIBODY-POSITIVE PATIENTS WITH FEVER - COMPARISON OF THE EFFICACY OF GA-67-CITRATE AND RADIOLABELED HUMAN-IGG 51
Macrophage targeting in experimental arthritis 51
FDG-PET in diagnosing central venous catheter related infection in stem cell transplant recipients 51
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using Ga-68-RGD PET/CT 51
F-18-FDG-PET/CT as a diagnostic tool in native valve endocarditis 51
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer 51
A modelling approach to estimate the FDG arterial plasma time activity curve in Patlak-based therapy response analysis 50
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise 50
IMPROVED SELECTION OF PATIENTS FOR HEPATIC SURGERY OF COLORECTAL LIVER METASTASES WITH FDG-PET: RESULTS OF THE RANDOMIZED DUTCH POLEM STUDY 50
Molecular imaging of hypoxia 50
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring F-18-FDG PET studies 50
Radiolabeled IL-1ra for detection of synovitis in patients with RA. Preliminary results. 50
99mTc-interleukin-8 for imaging acute osteomyelitis 50
Phase 1 Radioimmunotherapy Study with Lutetium 177-labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma 50
Liposomes for scintigraphic imaging: Optimization of in vivo behavior 50
Pharmacokinetics and tumor targeting of I-131-labeled F(ab ')(2) fragments of the chimeric monoclonal antibody G250: Preclinical and clinical pilot studies 50
WHICH FACTORS PREDICT THE RESULTS OF PITUITARY SURGERY IN ACROMEGALY 50
The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma 50
RADIOIMMUNOCONJUGATES IN THE DETECTION OF INFECTION AND INFLAMMATION 50
F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection 50
SPECT/CT-based Dosimetry for a Multicentre Trial of Selumetinib Enhanced Radioiodine Treatment of Differentiated Thyroid Cancer: Preliminary Results 49
INTERIM ANALYSIS OF A PHASE I RADIOIMMUNOTHERAPY STUDY IN ADVANCED RENAL CELL CARCINOMA PATIENTS USING LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250 49
Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer 49
INDIUM-111-LABELED HUMAN NONSPECIFIC IMMUNOGLOBULIN-G - A NEW RADIOPHARMACEUTICAL FOR IMAGING INFECTIOUS AND INFLAMMATORY FOCI 49
Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring 49
Pretargeted immuno-PET imaging and radioimmunotherapy of prostate cancer with an anti-EGP1 x anti-HSG bispecific antibody 49
FDG-PET and CT in the staging of melanoma patients with lymph node metastases; diagnostic performance and clinical consequences 49
Absorption and biodistribution of (111)indium-labelled desferrioxamine (In-111-DFO) after subcutaneous injection of In-111-DFO liposomes 49
Scintigraphic evaluation of experimental chronic osteomyelitis. 49
Tc-99m-CXCL8 SPECT to Monitor Disease Activity in Inflammatory Bowel Disease 49
Imaging of inflamed joints in patients with active rheumatoid arthritis with radiolabeled interleukin-1 receptor antagonist. Initial results. 49
Tracers to monitor the response to chemotherapy: In vitro screening of four radiopharmaceuticals 49
A bivalent leukotriene B-4 antagonist for scintigraphic Imaging of infectious foci 49
Megalin Plays an Important Role in the Renal Uptake of Various Radiolabeled Peptides: Studies in Megalin-Deficient Mice 49
Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma 48
SPECIFIC ANTIBODY UPTAKE IN TUBERCULOSIS 48
Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss 48
18F-FDG PET/CT in Detecting Metastatic Infection in Children 48
Molecular Imaging and Theranostics-A Multidisciplinary Approach 48
F-18-FDG PET/CT in Local Ablative Therapies: A Systematic Review 48
Incidental finding of malignancy in patients preoperatively evaluated for aneurysm wall pathology using PET/CT 48
Evaluation of the advanced ReSPECT image reconstruction software in a phantom model and in parathyroid scanning 48
Authors' reply: Value of fluorodeoxyglucose positron emission tomography in women with breast cancer 48
Using dynamic F-18-FDG PET for lung tumour segmentation and quantitative assessment of glucose metabolism for different histological types 48
Referred shoulder pain in a patient with small cell lung cancer 48
Dose escalation of Re-186-labeled humanized monoclonal antibody LL2 in patients with non-Hodgkin's lymphoma (NHL). 48
Comparison of potential of interleukin-1, its receptor antagonist and a chemotactic peptide for imaging of infection. 48
Inhibition of kidney uptake of radiolabeled somatostatin analogs: Amino acids or Gelofusine? Reply 48
Development of In-111-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination 48
[F-18]fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic e-cadherin mutation carrier 48
Y-86 and In-111 labeled alpha(V beta 3) binding peptides: A comparative dosimetric study in dogs. 48
A COMPARISON OF IN-111-HIG SCINTIGRAPHY AND CHEST RADIOLOGY IN THE IDENTIFICATION OF PULMONARY INFECTION IN PATIENTS WITH HIV-INFECTION 48
Radiation Exposure (Un)Awareness amongst nuclear medicine patients - a systematic review 48
Commonly used imaging techniques for diagnosis and staging 48
Cost-effectiveness of Adding FDG-PET or CT to the Diagnostic Work-up of Patients With Stage III Melanoma 48
Correlation of [F-18]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts 47
Rosuvastatin Increases Extracellular Adenosine Formation in Humans In Vivo A New Perspective on Cardiovascular Protection 47
F-18-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors 47
Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinoma 47
PET/CT imaging of angiogenesis in head and neck squamous cell carcinoma patients 47
Totale 5.197
Categoria #
all - tutte 293.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 293.906


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202080 0 0 0 0 0 0 0 0 0 0 0 80
2020/202112.072 13 14 35 19 43 3.751 1.701 567 2.520 2.209 3 1.197
2021/20224.624 79 16 98 1.388 3 6 125 845 434 328 1.014 288
2022/202317.894 2.482 630 1.667 1.829 1.924 1.631 9 1.746 3.327 1.394 999 256
2023/20245.000 649 910 1.757 184 209 609 136 381 90 69 6 0
Totale 39.670